EMERGENCY CONTRACEPTION: AN UPDATED REVIEW

被引:0
作者
Guida, M. [1 ]
Marra, M. L. [1 ]
Palatucci, V. [1 ]
Pascale, R. [1 ]
Visconti, F. [1 ]
Zullo, F. [1 ]
机构
[1] Univ Salerno, Dept Obstet Gynecol, Salerno, Italy
来源
TRANSLATIONAL MEDICINE AT UNISA | 2011年 / 1卷
关键词
emergency contraception; levonorgestrel; mifepristone; ulipristal acetate;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Emergency contraception is a common practice now. Many categories of drugs are marketed with modifications in dosage, in combination and even in the timing of administration. Recent re-analysis suggests that there is still no uniformity of opinion on the actual mechanism of action and this has often fueled the ethical controversy. This review analyzes the most common emergency contraception drugs: levonorgestrel, mifepristone and ulipristal acetate about their action underlining that the hormonal products, when used in emergency contraception, play different roles depending on the phase of the menstrual cycle during which they are administered. This review aims to examine rigorously the most accredited literature to verify if a evidence-based uniformity of opinions has been achieved about the biological effects of hormones administered after the sexual intercourse.
引用
收藏
页码:271 / 294
页数:24
相关论文
共 108 条
[1]  
Agarwal M, 2009, AM J OBSTET GYNECOL
[2]  
[Anonymous], 1995, RIPORTED PLANNED PAR, V24, P8
[3]  
[Anonymous], 1985, CONCISE MED DICT
[4]   Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians [J].
Arowojolu, AO ;
Okewole, IA ;
Adekunle, AO .
CONTRACEPTION, 2002, 66 (04) :269-273
[5]   Female contraception over 40 [J].
Baird, D. T. ;
Castelo-Branco, C. ;
Collins, J. ;
Evers, J. L. H. ;
Glasier, A. ;
La Vecchia, C. ;
Leridon, H. ;
Mishell, D. R., Jr. ;
Wellings, K. ;
Arisi, E. ;
Benagiano, G. ;
Bitzer, J. ;
Crosignani, P. G. ;
Diczfalusy, E. ;
Lanzone, A. ;
Skouby, S. O. ;
Stock, G. ;
Volpe, A. .
HUMAN REPRODUCTION UPDATE, 2009, 15 (06) :599-612
[6]  
BAIRD DT, 1995, HUM REPROD, V10, P2270
[7]   RU-486 AS AN ANTIPROGESTERONE STEROID - FROM RECEPTOR TO CONTRAGESTION AND BEYOND [J].
BAULIEU, EE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (13) :1808-1814
[8]   Development of the selective progesterone receptor modulator CDB-2914 for clinical indications [J].
Blithe, DL ;
Nieman, LK ;
Blye, RP ;
Stratton, P ;
Passaro, M .
STEROIDS, 2003, 68 (10-13) :1013-1017
[9]   CERVICAL-MUCUS CONCENTRATION OF PROSTAGLANDINS E(2) AND F2-ALPHA AFTER PRETREATMENT WITH MIFEPRISTONE IN THE FIRST TRIMESTER OF PREGNANCY [J].
BOKSTROM, H ;
NORSTROM, A ;
WIQVIST, N .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1995, 49 (01) :41-48
[10]  
Brown A, 2002, J CLIN ENDOCRINOL ME